Christian B. Voigtlander - 04 Mar 2024 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Signature
By: Paula Darbyshire, Attorney-in-fact For: Christian Voigtlander
Issuer symbol
ICUI
Transactions as of
04 Mar 2024
Net transactions value
-$1,458,090
Form type
4
Filing time
05 Mar 2024, 13:42:01 UTC
Previous filing
11 Sep 2023
Next filing
11 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Sale $735,314 -6,887 -51% $106.77 6,716 04 Mar 2024 Direct F1
transaction ICUI Common Stock Sale $699,060 -6,497 -97% $107.60 219 04 Mar 2024 Direct F2
transaction ICUI Common Stock Sale $23,717 -219 -100% $108.30 0 04 Mar 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.185 to $107.15 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.22 to $108.18, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.27 to $108.57, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.